Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue & Banking), End User, Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028
The stem cell manufacturing market is projected to reach USD 21.8 billion by 2028 from USD 12.7 billion in 2023, at a CAGR of 11.3% during the forecast period. The major factors driving the increasing prevalence of genetic diseases and increasing regulatory approvals on stem cell therapies are expected to propel the growth of the market. However, the high costs of research and manufacturing are expected to restrain market growth to a certain extent.
The stem cell manufacturing market has been segmented based on product, application, end-user, and region.
“By-products, the consumables segment accounted for the largest share of the stem cell manufacturing market.”
Based on products, the stem cell manufacturing market is categorized into consumables, instruments, and stem cell lines. The consumables segment dominated the market in 2023, owing to rising demand for stem cell-based research, increasing government funding and initiatives, and the rising number of collaborations between academic institutions and pharmaceutical companies has led to a higher growth rate for products in the stem cell manufacturing market.
“By application, research application segment accounted for the largest share in the stem cell manufacturing market.”
Based on application, the stem cell manufacturing market is segmented into research applications, clinical applications, and cell & tissue banking applications. In 2023, the research application segment accounted for a larger share of the stem cell manufacturing market. Growth in this market segment can be attributed to a rising focus on stem cell cytology & pathophysiology research, growing awareness about the therapeutic potency of stem cells among researchers and healthcare professionals, growing public-private funding to support stem cell product development and commercialization, and technological advancements related to the effective production scale-up for stem cell products.
“North America: the largest share of the stem cell manufacturing market”
North America accounted for the largest share of the stem cell manufacturing market. The large share of the North American region can be attributed to a well-established healthcare and biotechnology industry in the region, with advanced infrastructure, cutting-edge research institutions, and a strong ecosystem of biotechnology companies and CROs specializing in stem cell research. The presence of top academic institutions and private companies in North America with dedicated stem cell research programs and expertise has contributed to the growth of the stem cell manufacturing market.
“Asia Pacific: The fastest-growing region in the stem cell manufacturing market.”
The Asia Pacific stem cell manufacturing market is projected to grow at the highest CAGR during the forecast period. This is attributed to the increasing demand for personalized medicine and advancements in stem cell-based therapies. Another key driver for the Asia Pacific stem cell manufacturing market is the region's large and rapidly increasing population.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the stem cell manufacturing market. It aims at estimating the size and future growth potential of the market across different segments, such as the product (Consumables (culture media, and other consumables), instruments (Bioreactors & Incubators, cell sorters, and other instruments), and stem cell lines (hematopoietic stem cells, mesenchymal stem cells, induced pluripotent stem cells, embryonic stem cells, neural stem cells, and multipotent adult progenitor stem cells), application(research applications (life science research, and drug discovery and development), clinical applications (allogeneic stem cell therapy, and autologous stem cell therapy), and cell & tissue banking applications), and end-user (hospitals & surgical centers, pharmaceutical & biotechnology companies, cell & tissue banks, academic institutes, research laboratories, and CROs, and other end users) and region (North America, Europe, Asia Pacific, Latin America, and Middle East Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall stem cell manufacturing market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
The report provides insights on the following pointers:
The stem cell manufacturing market has been segmented based on product, application, end-user, and region.
“By-products, the consumables segment accounted for the largest share of the stem cell manufacturing market.”
Based on products, the stem cell manufacturing market is categorized into consumables, instruments, and stem cell lines. The consumables segment dominated the market in 2023, owing to rising demand for stem cell-based research, increasing government funding and initiatives, and the rising number of collaborations between academic institutions and pharmaceutical companies has led to a higher growth rate for products in the stem cell manufacturing market.
“By application, research application segment accounted for the largest share in the stem cell manufacturing market.”
Based on application, the stem cell manufacturing market is segmented into research applications, clinical applications, and cell & tissue banking applications. In 2023, the research application segment accounted for a larger share of the stem cell manufacturing market. Growth in this market segment can be attributed to a rising focus on stem cell cytology & pathophysiology research, growing awareness about the therapeutic potency of stem cells among researchers and healthcare professionals, growing public-private funding to support stem cell product development and commercialization, and technological advancements related to the effective production scale-up for stem cell products.
“North America: the largest share of the stem cell manufacturing market”
North America accounted for the largest share of the stem cell manufacturing market. The large share of the North American region can be attributed to a well-established healthcare and biotechnology industry in the region, with advanced infrastructure, cutting-edge research institutions, and a strong ecosystem of biotechnology companies and CROs specializing in stem cell research. The presence of top academic institutions and private companies in North America with dedicated stem cell research programs and expertise has contributed to the growth of the stem cell manufacturing market.
“Asia Pacific: The fastest-growing region in the stem cell manufacturing market.”
The Asia Pacific stem cell manufacturing market is projected to grow at the highest CAGR during the forecast period. This is attributed to the increasing demand for personalized medicine and advancements in stem cell-based therapies. Another key driver for the Asia Pacific stem cell manufacturing market is the region's large and rapidly increasing population.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 63% and Demand Side- 37%
- By Designation: C Level Executives - 45%, Director Level- 30%, and Others - 25%
- By Country: North America- 40%, Europe- 25%, Asia Pacific- 20%, Latin America - 10%, and Middle East Africa- 5%
- Thermo Fisher Scientific, Inc. (US)
- Merck KGaA (Germany)
- Lonza Group (Switzerland)
- Danaher Corporation (US)
- Sartorius AG (Germany)
- Becton, Dickinson, and Company (US)
- Eppendorf AG (Germany)
- Corning Inc. (US)
- Bio-Rad Laboratories (US)
- Takara Bio Group (Japan)
- Fujifilm Holdings Corporation (Japan)
- Getinge AB (Sweden)
- Terumo Corporation (Japan)
- Bio-Techne Corporation (US)
- HiMedia Laboratories (India)
- StemCell Technologies, Inc. (Canada)
- Miltenyi Biotec GmBH (Germany)
- PromoCell (Germany), Anterogen Co. Ltd. (South Korea)
- CellGenix GmBH (India)
- Pluristem Therapeutics Inc. (Israel)
- Daiichi Sankyo (Japan)
- Organogenesis Holdings Inc. (US)
- Vericel Corporation (US)
- American Cryostem Corporation (US)
This report provides a detailed picture of the stem cell manufacturing market. It aims at estimating the size and future growth potential of the market across different segments, such as the product (Consumables (culture media, and other consumables), instruments (Bioreactors & Incubators, cell sorters, and other instruments), and stem cell lines (hematopoietic stem cells, mesenchymal stem cells, induced pluripotent stem cells, embryonic stem cells, neural stem cells, and multipotent adult progenitor stem cells), application(research applications (life science research, and drug discovery and development), clinical applications (allogeneic stem cell therapy, and autologous stem cell therapy), and cell & tissue banking applications), and end-user (hospitals & surgical centers, pharmaceutical & biotechnology companies, cell & tissue banks, academic institutes, research laboratories, and CROs, and other end users) and region (North America, Europe, Asia Pacific, Latin America, and Middle East Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall stem cell manufacturing market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (growing venture capital investments in stem cell research, increasing awareness about the therapeutic potency of stem cell products, and technological advancements in stem cell manufacturing), restraints (significant operational costs associated with stem cell manufacturing and banking), opportunities (development of new vaccine and treatment of genetic diseases in Asia Pacific region, government initiatives to boost the biotechnology and biopharmaceutical industries, and increased market focus on mesenchymal stem cells and induced pluripotent stem cells), and challenges (technical limitations associated with manufacturing scale-up, and socio-ethical concerns related to the use of allogeneic and human embryonic stem cells) influencing the growth of the stem cell manufacturing market.
- Product Development/ Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the stem cell manufacturing market.
- Market Development: Comprehensive information about lucrative markets- the report analyses the stem cell manufacturing market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the stem cell manufacturing market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Merck KGaA (Germany), Lonza Group (Switzerland), and Danaher Corporation (US), among others, in the stem cell manufacturing market strategies. The report also helps stakeholders understand the pulse of the stem cell manufacturing market and provides them with information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY
1.6 RESEARCH LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
1.9 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 STEM CELL MANUFACTURING MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 STEM CELL MANUFACTURING MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
FIGURE 4 STEM CELL MANUFACTURING MARKET SIZE (2022)
FIGURE 5 STEM CELL MANUFACTURING MARKET: FINAL CAGR PROJECTIONS (2023?2028)
FIGURE 6 STEM CELL MANUFACTURING MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
2.3.1 DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 INDUSTRY INSIGHTS
2.5 RESEARCH ASSUMPTIONS
2.6 STEM CELL MANUFACTURING MARKET: GLOBAL RECESSION IMPACT
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 8 STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2023 VS. 2028 (USD MILLION)
FIGURE 9 STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2023 VS. 2028 (USD MILLION)
FIGURE 10 STEM CELL MANUFACTURING MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 STEM CELL MANUFACTURING MARKET OVERVIEW
FIGURE 11 GROWING INVESTMENTS IN STEM CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT AND COUNTRY (2023)
FIGURE 12 CONSUMABLES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2023
4.3 STEM CELL MANUFACTURING MARKET, BY END USER (2023 VS. 2028)
FIGURE 13 PHARMACEUTICAL & BIOTECH COMPANIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 14 STEM CELL MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 STEM CELL MANUFACTURING MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing venture capital investments in stem cell research
5.2.1.2 Increasing awareness about therapeutic potency of stem cell products
5.2.1.3 Technological advancements in stem cell manufacturing
5.2.2 RESTRAINTS
5.2.2.1 Significant operational costs associated with stem cell manufacturing and banking
5.2.3 OPPORTUNITIES
5.2.3.1 Supportive regulatory framework across developing economies
5.2.3.2 Government initiatives to boost biotechnology and biopharmaceutical industries
5.2.3.3 Increased market focus on mesenchymal stem cells and induced pluripotent stem cells
5.2.4 CHALLENGES
5.2.4.1 Technical limitations associated with manufacturing scale-up
5.2.4.2 Socio-ethical concerns related to use of allogeneic and human embryonic stem cells
5.3 TECHNOLOGY ANALYSIS
TABLE 5 SINGLE-USE BIOREACTORS VS. STAINLESS STEEL BIOREACTORS
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 16 STEM CELL MANUFACTURING MARKET: SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 17 STEM CELL MANUFACTURING MARKET: VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
FIGURE 18 STEM CELL MANUFACTURING MARKET: ECOSYSTEM ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 STEM CELL MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 INTENSITY OF COMPETITIVE RIVALRY
5.8.2 BARGAINING POWER OF SUPPLIERS
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 THREAT OF SUBSTITUTES
5.8.5 THREAT OF NEW ENTRANTS
5.9 REGULATORY ANALYSIS
5.9.1 FDA APPROVALS
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 PRICING ANALYSIS
TABLE 12 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS
5.10.1 AVERAGE SELLING PRICE TREND ANALYSIS
5.11 PATENT ANALYSIS
FIGURE 19 GRANTED PATENTS FOR STEM CELL MANUFACTURING, 2011–2023*
TABLE 13 TOP OWNERS OF STEM CELL MANUFACTURING PATENTS
5.12 KEY CONFERENCES & EVENTS IN 2023–2024
TABLE 14 STEM CELL MANUFACTURING CONFERENCES (2023–2024)
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 20 STEM CELL MANUFACTURING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
5.13.2 STEM CELL MANUFACTURING MARKET: BUYING CRITERIA
FIGURE 21 KEY BUYING CRITERIA FOR END USERS
6 STEM CELL MANUFACTURING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 15 STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
6.2 CONSUMABLES
TABLE 16 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE,
2021–2028 (USD MILLION)
TABLE 17 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 18 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 CULTURE MEDIA
6.2.1.1 Rising stem cell research and increasing demand for stem cell therapies to boost adoption of culture media
TABLE 21 STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY REGION, 2021–2028 (USD MILLION)
TABLE 22 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 EUROPE: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 OTHER CONSUMABLES
TABLE 25 STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES,
BY REGION, 2021–2028 (USD MILLION)
TABLE 26 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSTRUMENTS
TABLE 29 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 30 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 31 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 BIOREACTORS & INCUBATORS
6.3.1.1 Introduction of advanced bioreactors and incubators to contribute to market growth
TABLE 34 STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 CELL SORTERS
6.3.2.1 Development of novel cell sorting technologies such as microfluidics to drive market
TABLE 38 STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS,
BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 OTHER INSTRUMENTS
TABLE 42 STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 STEM CELL LINES
TABLE 46 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.1 HEMATOPOIETIC STEM CELLS
6.4.1.1 Increasing adoption of cord blood banking to boost market
TABLE 51 STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.2 MESENCHYMAL STEM CELLS
6.4.2.1 Ease of cell harvesting, processing, and preservation to drive adoption of MSCs
TABLE 55 STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.3 INDUCED PLURIPOTENT STEM CELLS
6.4.3.1 Increased adoption of iPSCs in research on cell therapies & regenerative medicine to fuel growth
TABLE 59 STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.4 EMBRYONIC STEM CELLS
6.4.4.1 Rising research activity in cancer precision medicine to contribute to segmental growth
TABLE 63 STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 64 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 EUROPE: STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.5 NEURAL STEM CELLS
6.4.5.1 Introduction of novel isolation and expansion techniques for NSCs to drive market
TABLE 67 STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 68 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 EUROPE: STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.6 MULTIPOTENT ADULT PROGENITOR STEM CELLS
6.4.6.1 Rising awareness of role of MAPCs in research to propel market
TABLE 71 STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY REGION, 2021–2028 (USD MILLION)
TABLE 72 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
7 STEM CELL MANUFACTURING MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 75 STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
7.2 RESEARCH APPLICATIONS
TABLE 76 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 77 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 78 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.1 LIFE SCIENCE RESEARCH
7.2.1.1 Increasing research focus on stem cell cytology & pathology to boost market
TABLE 81 STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH,
BY REGION, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.2 DRUG DISCOVERY & DEVELOPMENT
7.2.2.1 Increasing research expenditure by pharma and biotech companies to contribute to market growth
TABLE 85 STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 EUROPE: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 CLINICAL APPLICATIONS
TABLE 89 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 91 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.1 ALLOGENEIC STEM CELL THERAPY
7.3.1.1 Wide therapeutic applications of stem cell lines to drive growth
TABLE 94 STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY REGION, 2021–2028 (USD MILLION)
TABLE 95 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 EUROPE: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 97 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.2 AUTOLOGOUS STEM CELL THERAPY
7.3.2.1 Increasing patient preference for autologous stem cell therapy to drive segmental growth
TABLE 98 STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 EUROPE: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 CELL & TISSUE BANKING APPLICATIONS
7.4.1 RISING DEMAND FOR CORD BLOOD STEM CELL BANKING TO FAVOR MARKET GROWTH
TABLE 102 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 103 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 STEM CELL MANUFACTURING MARKET, BY END USER
8.1 INTRODUCTION
TABLE 106 STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 INCREASING PRIVATE INVESTMENTS FOR STEM CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
TABLE 107 STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 108 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2021–2028 (USD MILLION)
TABLE 109 EUROPE: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CONTRACT RESEARCH ORGANIZATIONS
8.3.1 INCREASED PUBLIC FUNDING FOR RESEARCH ACTIVITIES TO BOOST MARKET
TABLE 111 STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY REGION,
2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY,
2021–2028 (USD MILLION)
TABLE 113 EUROPE: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY,
2021–2028 (USD MILLION)
TABLE 114 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY,
2021–2028 (USD MILLION)
8.4 HOSPITALS & SURGICAL CENTERS
8.4.1 IMPROVED HEALTHCARE INFRASTRUCTURE TO PROPEL GROWTH
TABLE 115 STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 116 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 EUROPE: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 CELL & TISSUE BANKS
8.5.1 GROWING APPLICATION OF STEM CELLS IN DISEASE TREATMENT TO FAVOR MARKET GROWTH
TABLE 119 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY REGION, 2021–2028 (USD MILLION)
TABLE 120 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 OTHER END USERS
TABLE 123 STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 124 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
9 STEM CELL MANUFACTURING MARKET, BY REGION
9.1 INTRODUCTION
TABLE 127 STEM CELL MANUFACTURING MARKET, BY REGION,
2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: STEM CELL MANUFACTURING MARKET SNAPSHOT
TABLE 128 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 129 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 130 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 131 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 133 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 134 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 Continued focus to strengthen R&D to drive market in US
TABLE 137 US: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 138 US: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 139 US: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 US: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 US: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 142 US: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 143 US: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 144 US: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising government investments to drive market in Canada
TABLE 145 CANADA: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 146 CANADA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 147 CANADA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 148 CANADA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 CANADA: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 150 CANADA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 151 CANADA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 152 CANADA: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.2.3 NORTH AMERICA: IMPACT OF RECESSION
9.3 EUROPE
TABLE 153 EUROPE: STEM CELL MANUFACTURING MARKET, BY COUNTRY,
2021–2028 (USD MILLION)
TABLE 154 EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 155 EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 158 EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 159 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 160 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Strong growth in biotechnology industry to drive market
TABLE 162 GERMANY: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 163 GERMANY: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 164 GERMANY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 165 GERMANY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 GERMANY: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 167 GERMANY: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 GERMANY: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 GERMANY: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Government support in stem cell manufacturing to drive market
TABLE 170 FRANCE: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 171 FRANCE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 172 FRANCE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 FRANCE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 174 FRANCE: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 175 FRANCE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 FRANCE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 FRANCE: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.3 UK
9.3.3.1 Growing focus on innovation to increase demand for stem cell-based therapeutics
TABLE 178 UK: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 179 UK: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 180 UK: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 181 UK: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 UK: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 183 UK: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 184 UK: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 UK: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Initiatives encouraging development of cell & gene therapy to boost demand for stem cell manufacturing
TABLE 186 ITALY: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 187 ITALY: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 188 ITALY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 ITALY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 ITALY: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 191 ITALY: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 192 ITALY: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 193 ITALY: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing demand for precision medicine to drive growth
TABLE 194 SPAIN: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 195 SPAIN: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 196 SPAIN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 SPAIN: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 SPAIN: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 199 SPAIN: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 SPAIN: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 SPAIN: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 202 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 203 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 206 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 207 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 208 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 EUROPE: IMPACT OF RECESSION
9.4 ASIA PACIFIC
FIGURE 23 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET SNAPSHOT
TABLE 210 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY COUNTRY,
2021–2028 (USD MILLION)
TABLE 211 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 212 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 214 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 215 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 216 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 217 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICA
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY
1.6 RESEARCH LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
1.9 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 STEM CELL MANUFACTURING MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 STEM CELL MANUFACTURING MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
FIGURE 4 STEM CELL MANUFACTURING MARKET SIZE (2022)
FIGURE 5 STEM CELL MANUFACTURING MARKET: FINAL CAGR PROJECTIONS (2023?2028)
FIGURE 6 STEM CELL MANUFACTURING MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
2.3.1 DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 INDUSTRY INSIGHTS
2.5 RESEARCH ASSUMPTIONS
2.6 STEM CELL MANUFACTURING MARKET: GLOBAL RECESSION IMPACT
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 8 STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2023 VS. 2028 (USD MILLION)
FIGURE 9 STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2023 VS. 2028 (USD MILLION)
FIGURE 10 STEM CELL MANUFACTURING MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 STEM CELL MANUFACTURING MARKET OVERVIEW
FIGURE 11 GROWING INVESTMENTS IN STEM CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT AND COUNTRY (2023)
FIGURE 12 CONSUMABLES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2023
4.3 STEM CELL MANUFACTURING MARKET, BY END USER (2023 VS. 2028)
FIGURE 13 PHARMACEUTICAL & BIOTECH COMPANIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 14 STEM CELL MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 STEM CELL MANUFACTURING MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing venture capital investments in stem cell research
5.2.1.2 Increasing awareness about therapeutic potency of stem cell products
5.2.1.3 Technological advancements in stem cell manufacturing
5.2.2 RESTRAINTS
5.2.2.1 Significant operational costs associated with stem cell manufacturing and banking
5.2.3 OPPORTUNITIES
5.2.3.1 Supportive regulatory framework across developing economies
5.2.3.2 Government initiatives to boost biotechnology and biopharmaceutical industries
5.2.3.3 Increased market focus on mesenchymal stem cells and induced pluripotent stem cells
5.2.4 CHALLENGES
5.2.4.1 Technical limitations associated with manufacturing scale-up
5.2.4.2 Socio-ethical concerns related to use of allogeneic and human embryonic stem cells
5.3 TECHNOLOGY ANALYSIS
TABLE 5 SINGLE-USE BIOREACTORS VS. STAINLESS STEEL BIOREACTORS
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 16 STEM CELL MANUFACTURING MARKET: SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 17 STEM CELL MANUFACTURING MARKET: VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
FIGURE 18 STEM CELL MANUFACTURING MARKET: ECOSYSTEM ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 STEM CELL MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 INTENSITY OF COMPETITIVE RIVALRY
5.8.2 BARGAINING POWER OF SUPPLIERS
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 THREAT OF SUBSTITUTES
5.8.5 THREAT OF NEW ENTRANTS
5.9 REGULATORY ANALYSIS
5.9.1 FDA APPROVALS
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 PRICING ANALYSIS
TABLE 12 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS
5.10.1 AVERAGE SELLING PRICE TREND ANALYSIS
5.11 PATENT ANALYSIS
FIGURE 19 GRANTED PATENTS FOR STEM CELL MANUFACTURING, 2011–2023*
TABLE 13 TOP OWNERS OF STEM CELL MANUFACTURING PATENTS
5.12 KEY CONFERENCES & EVENTS IN 2023–2024
TABLE 14 STEM CELL MANUFACTURING CONFERENCES (2023–2024)
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 20 STEM CELL MANUFACTURING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
5.13.2 STEM CELL MANUFACTURING MARKET: BUYING CRITERIA
FIGURE 21 KEY BUYING CRITERIA FOR END USERS
6 STEM CELL MANUFACTURING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 15 STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
6.2 CONSUMABLES
TABLE 16 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE,
2021–2028 (USD MILLION)
TABLE 17 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 18 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 CULTURE MEDIA
6.2.1.1 Rising stem cell research and increasing demand for stem cell therapies to boost adoption of culture media
TABLE 21 STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY REGION, 2021–2028 (USD MILLION)
TABLE 22 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 EUROPE: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 OTHER CONSUMABLES
TABLE 25 STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES,
BY REGION, 2021–2028 (USD MILLION)
TABLE 26 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSTRUMENTS
TABLE 29 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 30 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 31 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 BIOREACTORS & INCUBATORS
6.3.1.1 Introduction of advanced bioreactors and incubators to contribute to market growth
TABLE 34 STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 CELL SORTERS
6.3.2.1 Development of novel cell sorting technologies such as microfluidics to drive market
TABLE 38 STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS,
BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 OTHER INSTRUMENTS
TABLE 42 STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 STEM CELL LINES
TABLE 46 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.1 HEMATOPOIETIC STEM CELLS
6.4.1.1 Increasing adoption of cord blood banking to boost market
TABLE 51 STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.2 MESENCHYMAL STEM CELLS
6.4.2.1 Ease of cell harvesting, processing, and preservation to drive adoption of MSCs
TABLE 55 STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR MESENCHYMAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.3 INDUCED PLURIPOTENT STEM CELLS
6.4.3.1 Increased adoption of iPSCs in research on cell therapies & regenerative medicine to fuel growth
TABLE 59 STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.4 EMBRYONIC STEM CELLS
6.4.4.1 Rising research activity in cancer precision medicine to contribute to segmental growth
TABLE 63 STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 64 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 EUROPE: STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.5 NEURAL STEM CELLS
6.4.5.1 Introduction of novel isolation and expansion techniques for NSCs to drive market
TABLE 67 STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 68 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 EUROPE: STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR NEURAL STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.6 MULTIPOTENT ADULT PROGENITOR STEM CELLS
6.4.6.1 Rising awareness of role of MAPCs in research to propel market
TABLE 71 STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY REGION, 2021–2028 (USD MILLION)
TABLE 72 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
7 STEM CELL MANUFACTURING MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 75 STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
7.2 RESEARCH APPLICATIONS
TABLE 76 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 77 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 78 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.1 LIFE SCIENCE RESEARCH
7.2.1.1 Increasing research focus on stem cell cytology & pathology to boost market
TABLE 81 STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH,
BY REGION, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.2 DRUG DISCOVERY & DEVELOPMENT
7.2.2.1 Increasing research expenditure by pharma and biotech companies to contribute to market growth
TABLE 85 STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 EUROPE: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 CLINICAL APPLICATIONS
TABLE 89 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY REGION, 2021–2028 (USD MILLION)
TABLE 91 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.1 ALLOGENEIC STEM CELL THERAPY
7.3.1.1 Wide therapeutic applications of stem cell lines to drive growth
TABLE 94 STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY REGION, 2021–2028 (USD MILLION)
TABLE 95 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 EUROPE: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 97 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.2 AUTOLOGOUS STEM CELL THERAPY
7.3.2.1 Increasing patient preference for autologous stem cell therapy to drive segmental growth
TABLE 98 STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 EUROPE: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 CELL & TISSUE BANKING APPLICATIONS
7.4.1 RISING DEMAND FOR CORD BLOOD STEM CELL BANKING TO FAVOR MARKET GROWTH
TABLE 102 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 103 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 STEM CELL MANUFACTURING MARKET, BY END USER
8.1 INTRODUCTION
TABLE 106 STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 INCREASING PRIVATE INVESTMENTS FOR STEM CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
TABLE 107 STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 108 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2021–2028 (USD MILLION)
TABLE 109 EUROPE: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CONTRACT RESEARCH ORGANIZATIONS
8.3.1 INCREASED PUBLIC FUNDING FOR RESEARCH ACTIVITIES TO BOOST MARKET
TABLE 111 STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY REGION,
2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY,
2021–2028 (USD MILLION)
TABLE 113 EUROPE: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY,
2021–2028 (USD MILLION)
TABLE 114 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY,
2021–2028 (USD MILLION)
8.4 HOSPITALS & SURGICAL CENTERS
8.4.1 IMPROVED HEALTHCARE INFRASTRUCTURE TO PROPEL GROWTH
TABLE 115 STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 116 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 EUROPE: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 CELL & TISSUE BANKS
8.5.1 GROWING APPLICATION OF STEM CELLS IN DISEASE TREATMENT TO FAVOR MARKET GROWTH
TABLE 119 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY REGION, 2021–2028 (USD MILLION)
TABLE 120 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 OTHER END USERS
TABLE 123 STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 124 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS,
BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
9 STEM CELL MANUFACTURING MARKET, BY REGION
9.1 INTRODUCTION
TABLE 127 STEM CELL MANUFACTURING MARKET, BY REGION,
2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: STEM CELL MANUFACTURING MARKET SNAPSHOT
TABLE 128 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 129 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 130 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 131 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 133 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 134 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 Continued focus to strengthen R&D to drive market in US
TABLE 137 US: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 138 US: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 139 US: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 US: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 US: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 142 US: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 143 US: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 144 US: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising government investments to drive market in Canada
TABLE 145 CANADA: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 146 CANADA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 147 CANADA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 148 CANADA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 CANADA: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 150 CANADA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 151 CANADA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 152 CANADA: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.2.3 NORTH AMERICA: IMPACT OF RECESSION
9.3 EUROPE
TABLE 153 EUROPE: STEM CELL MANUFACTURING MARKET, BY COUNTRY,
2021–2028 (USD MILLION)
TABLE 154 EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 155 EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 158 EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 159 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 160 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Strong growth in biotechnology industry to drive market
TABLE 162 GERMANY: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 163 GERMANY: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 164 GERMANY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 165 GERMANY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 GERMANY: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 167 GERMANY: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 GERMANY: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 GERMANY: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Government support in stem cell manufacturing to drive market
TABLE 170 FRANCE: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 171 FRANCE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 172 FRANCE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 FRANCE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 174 FRANCE: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 175 FRANCE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 FRANCE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 FRANCE: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.3 UK
9.3.3.1 Growing focus on innovation to increase demand for stem cell-based therapeutics
TABLE 178 UK: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 179 UK: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 180 UK: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 181 UK: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 UK: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 183 UK: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 184 UK: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 UK: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Initiatives encouraging development of cell & gene therapy to boost demand for stem cell manufacturing
TABLE 186 ITALY: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 187 ITALY: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 188 ITALY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 ITALY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 ITALY: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 191 ITALY: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 192 ITALY: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 193 ITALY: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing demand for precision medicine to drive growth
TABLE 194 SPAIN: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 195 SPAIN: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 196 SPAIN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 SPAIN: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 SPAIN: STEM CELL MANUFACTURING MARKET, BY APPLICATION,
2021–2028 (USD MILLION)
TABLE 199 SPAIN: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 SPAIN: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 SPAIN: STEM CELL MANUFACTURING MARKET, BY END USER,
2021–2028 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 202 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 203 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 206 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 207 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 208 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 EUROPE: IMPACT OF RECESSION
9.4 ASIA PACIFIC
FIGURE 23 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET SNAPSHOT
TABLE 210 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY COUNTRY,
2021–2028 (USD MILLION)
TABLE 211 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY PRODUCT,
2021–2028 (USD MILLION)
TABLE 212 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS,
BY TYPE, 2021–2028 (USD MILLION)
TABLE 214 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 215 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 216 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 217 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICA
